Prenetics Global Limited (PRE) — Titan Protect Analysis

PRE

Prenetics Global Limited

Healthcare · ·

$19.86

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$351M

Total market value of the company

Trailing P/E

N/A

Forward P/E

-30.37

Based on estimated future earnings — lower means cheaper

Rev Growth

N/A

Year-over-year revenue change

Profit Margin

-40.8%

How much profit the company keeps from each dollar of revenue

ROE

-22.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$30.00

+51% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 4 analysts covering this stock

About Prenetics Global Limited

Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositio

https://www.prenetics.com

Country: Hong Kong Employees: 98 Industry: Diagnostics & Research

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.126

Excellent risk-adjusted returns

Kelly Fraction

0.0586

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.662

Returns exceed worst-case losses — strong risk profile

Annual Return

85.3%

Historical annualised return based on price data

Max Drawdown

-51.3%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.15

Very low correlation to market moves

52W High

$23.63

16% below the year high

52W Low

$6.88

189% above the year low

Avg Volume

214,371

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-2.46

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

1.13

Meaningful debt load — monitor closely

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

52.8%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-37.2%

Profit from core operations before interest and tax

Free Cash Flow

$-73,027,000

Negative — the business is spending more than it generates

Revenue (TTM)

$92M

Total revenue over the last 12 months

Net Income

$-33,978,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$36.00

Target Median

$30.00

Target Low

$29.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
2026-05-05	Brian Babin	Republican	Sale	15K–50K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go